Promote an AI trading tool your audience will actually use — and get paid every month they stay subscribed. Free to try, easy to talk about, real recurring income.
ChartDNA grades any trade setup A+ → WAIT — entry, stop, three targets and risk/reward — on live data in about 10 seconds. Visitors can try it free with no signup, so there's nothing standing between your link and their first "wow".
Not a gimmick. Traders return daily to grade setups before they enter — which means subscriptions that stick, and commission that keeps paying.
One free analysis right on the homepage, no account. Then 10 free with a free account. Your audience feels the value before they pay.
Pro is $19.99/mo, Ultimate $39.99/mo. 30% for 12 months means a handful of active referrals is steady monthly income for you.
Fill in the short form below. We review every application personally.
We send your referral link, partner dashboard login, a media kit (banners + share cards), and a free Pro account so you can use it honestly.
Share your link. Your dashboard tracks clicks, signups and conversions. You earn 30% of everything each referral pays for 12 months.
You don't need a huge following — engaged beats big.
Tell us where you'd share ChartDNA. We'll get back to you by email with your link and a free Pro account.
Commissions are tracked in your partner dashboard, sourced directly from Stripe so the amounts are exact. Payouts are arranged with you on onboarding (typically monthly once you pass a small minimum).
Anyone who clicks your unique link and later subscribes to a paid plan. You earn 30% of what they pay, every month, for 12 months.
No. It's free to join, and we give you a free Pro account so you can use the tool honestly before promoting it.
No. It's an educational technical-analysis tool that grades setups and shows the reasoning — the trader always decides. That's usually a plus for creators who don't want liability.
Yes. Small and engaged converts best, and 30% recurring compounds over time.
ChartDNA.tech is an educational technical-analysis tool — not financial advice and not a regulated financial service. Partners must not promise profits, publish win-rate/accuracy claims, or imply regulatory endorsement. See the risk disclaimer.